Table 1.
Patient Characteristics
| Controls (n = 297) | EoE Cases (n = 120) | p-value* | |
|---|---|---|---|
| Age, median (IQR) | 55 (22) | 37 (15) | <0.0001 |
| White Race, n (%) | 234 (79) | 112 (93) | 0.0003 |
| Male Gender, n (%) | 112 (38) | 75 (63) | <0.0001 |
| Any atopic Disease, n (%) | 163 (60) | 83 (70) | 0.046 |
| Asthma, n (%) | 70 (26) | 33 (28) | 0.68 |
| Eczema, n (%) | 22 (8) | 9 (8) | 0.87 |
| Seasonal allergy, n (%) | 136 (50) | 74 (63) | 0.02 |
| Food allergy, n (%) | 44 (16) | 43 (36) | <0.0001 |
| Baseline EGD Findings, n (%) | |||
| Normal | 59 (20) | 3 (3) | <0.0001 |
| Rings | 37 (13) | 98 (82) | <0.0001 |
| Stricture | 55 (19) | 34 (28) | 0.03 |
| Narrowing | 13 (4) | 41 (34) | <0.0001 |
| Furrows | 19 (6) | 104 (87) | <0.0001 |
| Crepe paper | 3 (1) | 9 (8) | 0.0003 |
| White plaques | 13 (4) | 55 (46) | <0.0001 |
| Decreased vascularity | 9 (3) | 60 (50) | <0.0001 |
| Hiatal hernia | 125 (42) | 18 (15) | <0.0001 |
| Dilation | 95 (32) | 39 (33) | 0.92 |
| Baseline peak eosinophil count (eos/hpf), median (IQR) | 0 (2) | 104 (124) | <0.0001 |
*
p values presented are the result of Wilcoxon signed rank testing of continuous variables or χ2 testing of categorical variables.